0000914190-15-000294.txt : 20150811 0000914190-15-000294.hdr.sgml : 20150811 20150811163940 ACCESSION NUMBER: 0000914190-15-000294 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150807 FILED AS OF DATE: 20150811 DATE AS OF CHANGE: 20150811 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIO-TECHNE Corp CENTRAL INDEX KEY: 0000842023 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 411427402 STATE OF INCORPORATION: MN FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 614 MCKINLEY PL N E CITY: MINNEAPOLIS STATE: MN ZIP: 55413 BUSINESS PHONE: 6123798854 MAIL ADDRESS: STREET 1: 614 MCKINLEY PLACE NE CITY: MINNEAPOLIS STATE: MN ZIP: 55413 FORMER COMPANY: FORMER CONFORMED NAME: TECHNE CORP /MN/ DATE OF NAME CHANGE: 19920703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Eansor Norman David CENTRAL INDEX KEY: 0001270905 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-17272 FILM NUMBER: 151044384 MAIL ADDRESS: STREET 1: 8100 SOUTHPARK WAY, A-8 CITY: LITTLETON STATE: CO ZIP: 80120 FORMER NAME: FORMER CONFORMED NAME: EANSOR N DAVID DATE OF NAME CHANGE: 20031120 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2015-08-07 0000842023 BIO-TECHNE Corp TECH 0001270905 Eansor Norman David 8100 SOUTHPARK WAY, A-8 LITTLETON CO 80120 0 1 0 0 SVP - Novus Biologicals Common Stock 4469 D Stock Option (Right to Buy) 94.35 2021-08-12 Common Stock 15000 15000 D Stock Option (Right to Buy) 108.49 2015-08-07 4 A 0 12500 0 A 2022-08-07 Common Stock 12500 12500 D Stock Option (Right to Buy) 108.49 2015-08-07 4 A 0 6250 0 A 2022-08-07 Common Stock 6250 6250 D Restricted Stock Units 2015-08-07 4 A 0 1000 0 A Common Stock 1000 1000 D Includes 3,333 shares of restricted stock units that vest 1,667 shares on 7/1/16 and 1,666 shares on 7/1/17 (previously reported on Table II). 3,750 shares vest on each of 8/12/15, 8/12/16, 8/12/17 and 8/12/18. 3,125 shares vest on each of 8/7/16, 8/7/17, 8/7/18 and 8/7/19. Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. Vests in full or in part if certain performance goals are achieved during each of the 2016, 2017 and 2018 fiscal years. /s/ Elizabeth M. Dunshee as Attorney-in-Fact for David N. Eansor pursuant to Power of Attorney previously filed. 2015-08-11